ATAI
Price
$1.46
Change
+$0.07 (+5.04%)
Updated
Jan 17 closing price
Capitalization
244.99M
67 days until earnings call
LCTX
Price
$0.59
Change
+$0.02 (+3.51%)
Updated
Jan 17 closing price
Capitalization
129.47M
46 days until earnings call
Ad is loading...

ATAI vs LCTX

Header iconATAI vs LCTX Comparison
Open Charts ATAI vs LCTXBanner chart's image
ATAI Life Sciences
Price$1.46
Change+$0.07 (+5.04%)
Volume$961.55K
Capitalization244.99M
Lineage Cell Therapeutics
Price$0.59
Change+$0.02 (+3.51%)
Volume$715.24K
Capitalization129.47M
ATAI vs LCTX Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. LCTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and LCTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATAI: $1.46 vs. LCTX: $0.59)
Brand notoriety: ATAI and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 52% vs. LCTX: 24%
Market capitalization -- ATAI: $244.99M vs. LCTX: $129.47M
ATAI [@Biotechnology] is valued at $244.99M. LCTX’s [@Biotechnology] market capitalization is $129.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATAI and LCTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 5 TA indicator(s) are bullish while LCTX’s TA Score has 2 bullish TA indicator(s).

  • ATAI’s TA Score: 5 bullish, 5 bearish.
  • LCTX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than LCTX.

Price Growth

ATAI (@Biotechnology) experienced а -2.67% price change this week, while LCTX (@Biotechnology) price change was +1.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ATAI is expected to report earnings on May 20, 2025.

LCTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($245M) has a higher market cap than LCTX($129M). LCTX YTD gains are higher at: 16.896 vs. ATAI (9.774). LCTX has higher annual earnings (EBITDA): -22.1M vs. ATAI (-124.33M). ATAI has more cash in the bank: 85.9M vs. LCTX (32.7M). LCTX has less debt than ATAI: LCTX (2.75M) vs ATAI (23.8M). LCTX has higher revenues than ATAI: LCTX (8.72M) vs ATAI (331K).
ATAILCTXATAI / LCTX
Capitalization245M129M190%
EBITDA-124.33M-22.1M563%
Gain YTD9.77416.89658%
P/E RatioN/AN/A-
Revenue331K8.72M4%
Total Cash85.9M32.7M263%
Total Debt23.8M2.75M865%
FUNDAMENTALS RATINGS
ATAI vs LCTX: Fundamental Ratings
ATAI
LCTX
OUTLOOK RATING
1..100
7623
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
5364
P/E GROWTH RATING
1..100
1767
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (41) in the null industry is somewhat better than the same rating for ATAI (79) in the Miscellaneous Commercial Services industry. This means that LCTX’s stock grew somewhat faster than ATAI’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as ATAI (100) in the Miscellaneous Commercial Services industry. This means that LCTX’s stock grew similarly to ATAI’s over the last 12 months.

LCTX's SMR Rating (96) in the null industry is in the same range as ATAI (98) in the Miscellaneous Commercial Services industry. This means that LCTX’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's Price Growth Rating (53) in the Miscellaneous Commercial Services industry is in the same range as LCTX (64) in the null industry. This means that ATAI’s stock grew similarly to LCTX’s over the last 12 months.

ATAI's P/E Growth Rating (17) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for LCTX (67) in the null industry. This means that ATAI’s stock grew somewhat faster than LCTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAILCTX
RSI
ODDS (%)
Bearish Trend 5 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 20 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+5.04%
NTLA - ATAI
46%
Loosely correlated
+0.85%
FATE - ATAI
45%
Loosely correlated
+1.60%
MNMD - ATAI
45%
Loosely correlated
+9.91%
ABCL - ATAI
45%
Loosely correlated
+1.02%
CRSP - ATAI
44%
Loosely correlated
+0.57%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with GBIO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+2.80%
GBIO - LCTX
36%
Loosely correlated
+0.18%
APTO - LCTX
34%
Loosely correlated
+3.33%
MGTX - LCTX
34%
Loosely correlated
+5.56%
VTGN - LCTX
32%
Poorly correlated
N/A
ATAI - LCTX
30%
Poorly correlated
+5.04%
More